| 0.9 |
2.8 |
GO:1904685 |
positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.9 |
2.8 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.7 |
5.5 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.6 |
6.7 |
GO:0014883 |
transition between fast and slow fiber(GO:0014883) |
| 0.6 |
1.7 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) synaptic vesicle lumen acidification(GO:0097401) |
| 0.6 |
1.7 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.5 |
1.5 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.5 |
2.3 |
GO:1904721 |
regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.4 |
1.3 |
GO:1905154 |
negative regulation of tumor necrosis factor secretion(GO:1904468) negative regulation of membrane invagination(GO:1905154) |
| 0.4 |
1.2 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.4 |
1.2 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.4 |
2.7 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.3 |
0.9 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) glutamate secretion, neurotransmission(GO:0061535) |
| 0.3 |
0.8 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.3 |
1.3 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.3 |
1.3 |
GO:0060279 |
positive regulation of ovulation(GO:0060279) |
| 0.2 |
0.7 |
GO:1902219 |
maintenance of blood-brain barrier(GO:0035633) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.2 |
1.4 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.2 |
0.9 |
GO:0060266 |
negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
| 0.2 |
1.1 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
| 0.2 |
0.6 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.2 |
0.6 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.2 |
2.0 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.2 |
0.5 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 0.2 |
1.1 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.2 |
0.5 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.2 |
0.8 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.2 |
0.8 |
GO:0021905 |
pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) |
| 0.2 |
0.9 |
GO:0042795 |
snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 |
0.4 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.1 |
0.6 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 |
0.8 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 |
0.5 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.1 |
0.5 |
GO:0015819 |
lysine transport(GO:0015819) |
| 0.1 |
1.1 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.1 |
0.7 |
GO:0042045 |
epithelial fluid transport(GO:0042045) |
| 0.1 |
0.8 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 |
0.1 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.1 |
0.6 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 |
0.7 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.1 |
0.5 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) cellular response to potassium ion starvation(GO:0051365) |
| 0.1 |
0.6 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.1 |
0.3 |
GO:0045659 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.1 |
0.5 |
GO:0090164 |
protein retention in Golgi apparatus(GO:0045053) asymmetric Golgi ribbon formation(GO:0090164) |
| 0.1 |
1.5 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
0.8 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 |
1.3 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.1 |
0.2 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.1 |
0.9 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.1 |
0.8 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.1 |
0.5 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.1 |
0.2 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.1 |
0.7 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 |
0.8 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
0.8 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
0.3 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
| 0.1 |
1.3 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 |
0.7 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.1 |
0.3 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.1 |
1.6 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.1 |
0.3 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.1 |
0.3 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.1 |
0.8 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 |
0.2 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.1 |
0.3 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.1 |
0.4 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.1 |
1.4 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.1 |
0.3 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 |
0.4 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 |
0.4 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.1 |
2.2 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.1 |
0.2 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.0 |
0.6 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 |
0.2 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.0 |
0.3 |
GO:0032811 |
negative regulation of epinephrine secretion(GO:0032811) |
| 0.0 |
0.3 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 0.0 |
0.3 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.0 |
1.6 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.0 |
1.0 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.0 |
0.4 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.0 |
0.2 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.0 |
0.2 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.0 |
0.9 |
GO:0046325 |
negative regulation of glucose import(GO:0046325) |
| 0.0 |
0.8 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.3 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.0 |
0.6 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.0 |
0.2 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.0 |
1.2 |
GO:0045879 |
negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.0 |
0.2 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.0 |
0.2 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.0 |
0.2 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.0 |
0.5 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 |
0.4 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 |
0.2 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.0 |
0.3 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.0 |
0.3 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.0 |
0.4 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 |
0.3 |
GO:0030432 |
peristalsis(GO:0030432) |
| 0.0 |
0.7 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.0 |
0.2 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.0 |
0.1 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.0 |
0.2 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.0 |
0.5 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.0 |
0.1 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.0 |
0.1 |
GO:0003289 |
atrial septum primum morphogenesis(GO:0003289) |
| 0.0 |
0.1 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.0 |
0.5 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.0 |
1.6 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.0 |
0.3 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.5 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.0 |
0.6 |
GO:0051926 |
negative regulation of calcium ion transport(GO:0051926) |
| 0.0 |
0.1 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.0 |
0.5 |
GO:0031670 |
cellular response to nutrient(GO:0031670) |
| 0.0 |
0.4 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.0 |
0.1 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.0 |
0.1 |
GO:0051660 |
cortical microtubule organization(GO:0043622) establishment of centrosome localization(GO:0051660) |
| 0.0 |
0.5 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.0 |
1.4 |
GO:0035914 |
skeletal muscle cell differentiation(GO:0035914) |
| 0.0 |
0.3 |
GO:0060259 |
regulation of feeding behavior(GO:0060259) |
| 0.0 |
0.5 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.0 |
0.2 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.0 |
0.2 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.0 |
0.4 |
GO:0051489 |
regulation of filopodium assembly(GO:0051489) |
| 0.0 |
0.3 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.0 |
0.1 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.0 |
0.1 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.0 |
0.2 |
GO:0000054 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.0 |
0.1 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.0 |
0.2 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
0.3 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 0.0 |
0.3 |
GO:0044253 |
positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.0 |
0.4 |
GO:0050982 |
detection of mechanical stimulus(GO:0050982) |
| 0.0 |
0.1 |
GO:0003094 |
glomerular filtration(GO:0003094) |
| 0.0 |
0.6 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 |
0.9 |
GO:0003073 |
regulation of systemic arterial blood pressure(GO:0003073) |
| 0.0 |
0.1 |
GO:0010886 |
positive regulation of cholesterol storage(GO:0010886) negative regulation of cholesterol efflux(GO:0090370) |
| 0.0 |
0.4 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.0 |
0.4 |
GO:0010389 |
regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
| 0.0 |
0.0 |
GO:0002360 |
T cell lineage commitment(GO:0002360) CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
| 0.0 |
0.5 |
GO:0035196 |
production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
| 0.0 |
0.4 |
GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.0 |
0.4 |
GO:0045739 |
positive regulation of DNA repair(GO:0045739) |
| 0.0 |
0.1 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.0 |
0.2 |
GO:1904872 |
regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
| 0.0 |
0.9 |
GO:0001837 |
epithelial to mesenchymal transition(GO:0001837) |
| 0.0 |
0.4 |
GO:1900046 |
regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
| 0.0 |
0.7 |
GO:0030968 |
endoplasmic reticulum unfolded protein response(GO:0030968) |
